Biomarkers and severe asthma: a critical appraisal

Severe asthma (SA) is a clinically and etiologically heterogeneous respiratory disease which affects among 5–10 % of asthmatic patients. Despite high-dose therapy, a large patients percentage is not fully controlled and has a poor quality of life. In this review, we describe the biomarkers actually...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiappori, Alessandra, De Ferrari, Laura, Folli, Chiara, Mauri, Pierluigi, Riccio, Anna Maria, Canonica, Giorgio Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590266/
https://www.ncbi.nlm.nih.gov/pubmed/26430389
http://dx.doi.org/10.1186/s12948-015-0027-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590266/
https://www.ncbi.nlm.nih.gov/pubmed/26430389
http://dx.doi.org/10.1186/s12948-015-0027-7

Ejemplares similares